Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients

Eur J Heart Fail. 2024 Jan;26(1):140-141. doi: 10.1002/ejhf.3098. Epub 2023 Dec 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Heart Failure*
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Myocardial Infarction* / drug therapy
  • Spironolactone

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone